Januvia is a prescription drug used to treat type 2 diabetes. Learn about the common, mild, ... (FDA) approves a drug, it tracks and reviews side effects of the medication.

Januvia is a prescription drug used to help treat type 2 diabetes in adults. Learn how to find savings, lower long-term costs, and more.

Positive Opinion For Type 2 Diabetes Treatment, JANUVIA - First In New Class Of Oral Treatments Known As DPP-4 Inhibitors, European Union JANUVIA (sitagliptin), Merck, Sharp & Dohme's treatment ...

The US Food and Drug Administration has agreed to review Merck & Co’s application to market its experimental diabetes drug, Januvia (sitagliptin phosphate), placing the firm ahead of the pack in the ...

The U.S. Food and Drug Administration (FDA) warned that Type 2 diabetes drugs in the Dipeptidyl peptidase-4 (DPP-4) inhibitors class may cause severe joint pain. Januvia/Janumet (Sitagliptin) was ...

Januvia (sitagliptin) is a medication for type 2 diabetes. Along with diet and exercise, it can help lower blood sugar levels. Medicare Part D will generally cover prescription drugs, like Januvia ...

Medicare typically covers prescription drugs, such as Januvia, from Part D plans. Januvia costs with Medicare The cost of Januvia (sitagliptin) varies by dosage, a person’s plan type, and their ...

Pressure is building to take a deeper dive into the cancer risks of incretin mimetics, a class of drugs for Type 2 diabetes that includes blockbusters like Merck's Januvia and Novo Nordisk's Victoza.

Diabetes drugs including Merck & Co.’s Januvia, Bristol-Myers Squibb Co.’s Byetta and Novo Nordisk A/S’s Victoza are being scrutinized by U.S. regulators for a possible link to pre-cancerous ...

Testing found nitrosamine contamination in some samples of Januvia, but regulators will allow Merck to continue selling the drug for now. By Andrew Jacobs The Food and Drug Administration said ...

Merck’s MRK stock was up 3.5% on Thursday after a U.S. district court ruled in its favor in a patent infringement lawsuit against Viatris VTRS related to sitagliptin. Sitagliptin is the active ...